DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
35	天疱瘡	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03762265 (ClinicalTrials.gov)	January 8, 2019	29/11/2018	A Study of PRN1008 in Patients With Pemphigus	A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor PRN1008 in Moderate to Severe Pemphigus	Pemphigus	Drug: PRN1008 Oral Tablet;Drug: Placebo Oral Tablet	Principia Biopharma Inc.	NULL	Recruiting	18 Years	80 Years	All	120	Phase 3	United States;Argentina;Australia;Bulgaria;Canada;Croatia;France;Germany;Greece;Israel;Italy;Poland;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03762265
(ClinicalTrials.gov)

January 8, 2019

29/11/2018

A Study of PRN1008 in Patients With Pemphigus

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor PRN1008 in Moderate to Severe Pemphigus

Pemphigus

Drug: PRN1008 Oral Tablet;Drug: Placebo Oral Tablet

Principia Biopharma Inc.

NULL

Recruiting

18 Years

80 Years

All

120

Phase 3

United States;Argentina;Australia;Bulgaria;Canada;Croatia;France;Germany;Greece;Israel;Italy;Poland;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom